Meyka Pro banner
Freenome, Inc.

Freenome, Inc. (FRNM) Stock Overview

Explore Freenome, Inc.’s financial performance, market position, analyst ratings, and future outlook.

FRNM●NASDAQ
HealthcareMedical - Diagnostics & Research
$15.92
$0.27(1.67%)
U.S. Market opens in NaNh NaNm

Freenome, Inc. (FRNM)

Meyka AI Score

Z

Key Financials

Market Cap129.9M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$19.30
3 Months$35.78
1 Year Target$42.10

FRNM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Freenome, Inc. (NASDAQ: FRNM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Freenome, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FRNM on the NASDAQ shows an RSI of 56.90, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $42.10 for the NASDAQ listing.

Key metrics behind Freenome, Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 129.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FRNM on the NASDAQ.

Price Performance (NASDAQ: FRNM)

1-Day Change
-1.67%
5-Day Change
2.25%
1-Month Change
7.64%
3-Month Change
45.79%
6-Month Change
44.60%
Year-to-Date (YTD) Change
44.60%
1-Year Change
44.60%
3-Year Change
44.60%
5-Year Change
44.60%
All-Time (Max) Change
44.60%

Contact Information

NaN
3300 Marina Boulevard, Brisbane, CA, 94005

Company Facts

3,780 Employees
IPO DateJul 21, 2026
CountryUS
Actively Trading

Frequently Asked Questions